PDGFRB and breast cancer: Previous studies have shown that the autocrine PDGF/PDGFR signaling pathway promotes breast cancer progression [5] and that inhibiting PDGFR-A expression or activity by reducing its phosphorylation is an effective strategy for molecular therapy in breast cancer or other tumors [36].